🇺🇸 AMPH — Amphastar Pharmaceuticals, Inc.

Salud Mantener
← Volver

Precio actual

27,03 USD

Máx. histórico

65,00

1182 días

Caída desde máximo

-58,42%

Rango 52 semanas

16,65 – 29,52

Variación hoy

-2,49%

Cierre anterior

27,72

Rango de hoy

26,69 – 27,72

Volumen hoy

497.700

Peor caída histórica

-74,05%

08/08/2023 → 15/05/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

42,87%

Información
Nombre completo
Amphastar Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.976
PER ⓘ
15,99 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
22,50 USD (puede no estar actualizado)
Primera cotización
25/06/2014
Precio actualizado
hace 23 horas
Sobre la empresa

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/09/2014 12,11 12,25 11,81 12,00 -0,74% 3,63% 115.400
29/08/2014 11,55 12,26 11,55 12,09 +4,40% 6,15% 155.000
28/08/2014 11,41 11,72 11,39 11,58 +1,94% 2,89% 50.600
27/08/2014 11,50 11,90 11,33 11,36 -1,22% 4,96% 107.800
26/08/2014 11,56 12,18 11,27 11,50 +0,35% 7,87% 154.700
25/08/2014 10,15 11,69 10,06 11,46 +13,24% 16,06% 183.400
22/08/2014 10,00 10,40 10,00 10,12 +0,50% 4,00% 64.300
21/08/2014 10,03 10,34 9,84 10,07 -0,10% 4,99% 41.500
20/08/2014 10,05 10,30 9,80 10,08 +0,70% 4,98% 64.000
19/08/2014 9,96 10,05 9,76 10,01 -0,10% 2,91% 101.200
18/08/2014 10,14 10,16 9,95 10,02 -1,28% 2,07% 42.700
15/08/2014 10,37 10,40 10,00 10,15 +0,20% 3,86% 159.000
14/08/2014 10,15 10,24 10,01 10,13 -0,20% 2,27% 47.900
13/08/2014 9,80 10,15 9,59 10,15 -0,49% 5,71% 197.800
12/08/2014 10,11 10,30 9,80 10,20 +2,00% 4,95% 91.900
11/08/2014 10,03 10,54 9,99 10,00 +0,00% 5,48% 191.100
08/08/2014 9,45 10,40 9,45 10,00 +5,82% 10,05% 194.800
07/08/2014 9,68 9,68 9,05 9,45 +0,11% 6,51% 165.300
06/08/2014 9,37 9,75 9,02 9,44 +7,89% 7,79% 210.900
05/08/2014 8,75 8,93 8,71 8,75 -0,91% 2,51% 38.600
04/08/2014 8,97 9,15 8,77 8,83 -0,11% 4,24% 24.400
01/08/2014 8,84 9,39 8,76 8,84 -0,45% 7,13% 38.300
31/07/2014 8,92 9,20 8,76 8,88 -1,77% 4,93% 30.200
30/07/2014 9,11 9,50 8,92 9,04 -0,88% 6,37% 83.600
29/07/2014 9,04 9,26 8,92 9,12 +1,67% 3,76% 83.000
28/07/2014 9,05 9,09 8,90 8,97 -0,11% 2,10% 46.200
25/07/2014 9,05 9,23 8,92 8,98 -2,60% 3,43% 131.900
24/07/2014 9,20 9,94 9,05 9,22 +0,88% 9,67% 116.500
23/07/2014 9,35 9,62 9,05 9,14 -3,79% 6,10% 112.100
22/07/2014 9,11 10,10 9,11 9,50 +1,60% 10,87% 264.100